Local AI-Based Medical Devices Encouraged to Enter the Market
Efforts to promote self-reliance in domestic medical devices are increasingly focusing on the integration of digital technology. A collaboration between PT Darya-Varia Laboratoria Tbk and PT Astra Komponen Indonesia (Aski) has produced health devices based on artificial intelligence (AI) and the Internet of Things (IoT), claimed to meet the needs of independent health monitoring.
The product launch took place at Aski’s manufacturing facility and was attended by Health Minister Budi Gunadi Sadikin. During the visit, the government also inspected the production line as well as research and development facilities to ensure the readiness of the local industry in producing technology-based medical devices.
Of the six devices introduced, two are direct results of the collaboration between the two companies: DiViLab Optima (4 in 1) and DiViLab Core (3 in 1).
Both devices are designed to integrate various health examination functions into a single unit, from blood pressure to metabolic parameters such as blood sugar, cholesterol, and uric acid.
DiViLab Optima is described as a multifunctional device that combines four measurements simultaneously in a connected system. Meanwhile, DiViLab Core offers a more compact version with three main parameters.
Both are equipped with health trend monitoring features, AI-based predictive analytics, and support for remote monitoring by family or medical personnel.
President Director of Darya-Varia, Ian Kloer, views this development as a strategic step to expand public access to technology-based health monitoring.
“The collaboration with ASKI reflects our commitment to delivering domestic medical device innovations that are not only competitive but also relevant to the needs of Indonesian society,” he stated, as quoted on Thursday (2/4).
“The development of DiViLab Optima and DiViLab Core is a strategic step in providing technology-based health monitoring solutions that support national health programmes, particularly in increasing awareness and access to self-screening,” he added.
On the other hand, the development of local medical devices is also driven by the increasing capacity of the domestic industry. ASKI has developed more than 30 types of products with a domestic content level (TKDN) of 40%-59%.
The trend of using local products continues to rise, in line with claims of improved quality and reliability that are deemed capable of competing with imported products.
The collaboration is seen as reflecting a new direction for the national health industry, which not only focuses on production but also on data and technology integration.
With this approach, industry players hope to accelerate the adoption of digital health solutions while strengthening the position of domestic products in a market that has long been dominated by global products.